|
gptkbp:instance_of
|
gptkb:drug
|
|
gptkbp:activities
|
prevents ovulation
thickens cervical mucus
thins uterine lining
|
|
gptkbp:appointed_by
|
oral tablet
|
|
gptkbp:approves
|
gptkb:2006
gptkb:FDA
|
|
gptkbp:brand
|
gptkb:Jolessa
|
|
gptkbp:class
|
combination oral contraceptive
|
|
gptkbp:clinical_trial
|
studied for efficacy
studied for safety
studied for side effects
|
|
gptkbp:contains
|
gptkb:norethindrone
gptkb:ethinyl_estradiol
|
|
gptkbp:contraindication
|
liver disease
smoking
certain cancers
history of blood clots
|
|
gptkbp:developed_by
|
gptkb:Teva_Pharmaceuticals
|
|
gptkbp:dosage_form
|
21-day regimen
28-day regimen
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Jolessa
|
|
gptkbp:ingredients
|
gptkb:norethindrone
gptkb:ethinyl_estradiol
|
|
gptkbp:interacts_with
|
antibiotics
antiretrovirals
anticonvulsants
|
|
gptkbp:is_available_on
|
generic version
|
|
gptkbp:is_used_for
|
birth control
|
|
gptkbp:marketed_as
|
gptkb:Teva_Pharmaceuticals_USA
gptkb:Australia
gptkb:United_Kingdom
gptkb:United_States
gptkb:Native_American_tribe
|
|
gptkbp:previous_name
|
ethinyl estradiol and norethindrone
|
|
gptkbp:requires
|
gptkb:theorem
|
|
gptkbp:scholarships
|
not for use during pregnancy
report unusual bleeding
monitor for side effects
consult doctor before use
|
|
gptkbp:side_effect
|
headache
nausea
weight gain
breast tenderness
|
|
gptkbp:storage
|
room temperature
away from moisture
away from light
|
|
gptkbp:bfsParent
|
gptkb:ethinylestradiol
|
|
gptkbp:bfsLayer
|
6
|